Company: HCWB
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-058961
Chunk: 41

Company: HCW Biologics Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 41
---
                     | 9/8/2021   |                 |  13,000 |     | 7,000 (8)         |                            4.31 | 9/8/2031               |

(1) All of the outstanding equity awards were granted under our 2021 Plan and are subject to acceleration of vesting as described in above. (2) This column represents the fair market value of a share of our common stock on the date of grant. (3) These option shares were part of a stock option grant covering 800,000 shares of our common stock. 40% of the total shares subject to the stock option grant have vested as of September 8, 2023; 25% of the total shares subject to the stock option grant will vest on September 8, 2024; and 35% of the total shares subject to the stock option grant will vest on September 8, 2025, subject to Dr. Wong’s continuous service through the applicable vesting date. (4) These option shares were part of a stock option grant covering 135,000 shares of our common stock All of the shares subject to the stock option grant have vested. (5) These option shares were part of a stock option grant covering 80,000 shares of our common stock. 40% of the total shares subject to the stock option grant have vested as of September 8, 2023; 25% of the total shares subject to the stock option grant will vest on September 8, 2024; and 35% of the total shares subject to the stock option grant will vest on September 8, 2025, subject to Ms. Byam’s continuous service through the applicable vesting date. (6) These option shares were part of a stock option grant covering 85,713 shares of our common stock. All of the shares subject to the stock option grant have vested. (7) These option shares were part of a stock option grant covering 8,571 shares of our common stock. All of the shares subject to the stock option grant have vested. (8) These option shares were part of a stock option grant covering 20,000 shares of our common stock. 40% of the total shares subject to the stock option grant have vested as of September 8, 2023; 25% of the total shares subject to the stock option grant will vest on September 8, 2024; and 35%